首页> 美国卫生研究院文献>Molecular Oncology >Dysregulation of the miR‐194–CUL4B negative feedback loop drives tumorigenesis in non‐small‐cell lung carcinoma
【2h】

Dysregulation of the miR‐194–CUL4B negative feedback loop drives tumorigenesis in non‐small‐cell lung carcinoma

机译:miR‐194–CUL4B负反馈环的失调驱动非小细胞肺癌的肿瘤发生

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cullin 4B (CUL4B), a scaffold protein that assembles CRL4B ubiquitin ligase complexes, is overexpressed in many types of cancers and represses many tumor suppressors through epigenetic mechanisms. However, the mechanisms by which CUL4B is upregulated remain to be elucidated. Here, we show that CUL4B is upregulated in non‐small‐cell lung carcinoma (NSCLC) tissues and is critically required for cell proliferation and migration in vitro and for xenograft tumor formation in vivo. We found that microRNA‐194 (miR‐194) and CUL4B protein were inversely correlated in cancer specimens and demonstrated that miR‐194 could downregulate CUL4B by directly targeting its 3′‐UTR. We also showed that CUL4B could be negatively regulated by p53 in a miR‐194‐dependent manner. miR‐194 was further shown to attenuate the malignant phenotype of lung cancer cells by downregulating CUL4B. Interestingly, CRL4B also epigenetically represses miR‐194 by catalyzing monoubiquitination at H2AK119 and by coordinating with PRC2 to promote trimethylation at H3K27 at the gene clusters encoding miR‐194. RBX1, another component in CRL4B complex, is also targeted by miR‐194 in style="fixed-case">NSCLC cells. Our results thus establish a double‐negative feedback loop between miR‐194 and style="fixed-case">CRL4B, dysregulation of which contributes to tumorigenesis. The function of miR‐194 as a negative regulator of style="fixed-case">CUL4B has therapeutic implications in lung cancer.
机译:Cullin 4B(CUL4B)是一种组装CRL4B泛素连接酶复合物的支架蛋白,在许多类型的癌症中过表达,并通过表观遗传机制抑制许多肿瘤抑制因子。但是,CUL4B上调的机制仍有待阐明。在这里,我们显示CUL4B在非小细胞肺癌(NSCLC)组织中上调,并且是细胞在体外的细胞增殖和迁移以及在体内异种移植肿瘤形成的关键条件。我们发现microRNA‐194(miR‐194)和CUL4B蛋白在癌症标本中呈负相关,并证明miR‐194可以通过直接靶向其3'‐UTR来下调CUL4B。我们还表明,p53可能以miR-194依赖性方式对CUL4B产生负调控。进一步显示,miR-194通过下调CUL4B来减弱肺癌细胞的恶性表型。有趣的是,CRL4B还通过在H2AK119催化单泛素化并与PRC2协同促进H3K27编码miR-194的基因簇上的三甲基化,从而表观抑制miR-194。 miR-194在 style =“ fixed-case”> NSCLC 细胞中也靶向CRL4B复合体中的另一种成分RBX1。因此,我们的结果在miR-194与 style =“ fixed-case”> CRL 4B之间建立了一个双负反馈回路,其失调有助于肿瘤发生。 miR-194作为 style =“ fixed-case”> CUL 4B负调节剂的功能在肺癌中具有治疗意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号